Ultima-HCG 10000iu

Manufacturer: Ultima Pharmaceuticals

Pharmaceutical name: Human Chorionic Gonadotropin

Pack: 1 vial (10000iu)

HCG is a hormone that the female placenta produces naturally throughout a typical pregnancy. Its function closely resembles that of luteinizing hormone (LH), which is known to trigger ovulation. When used alongside other medications, HCG can effectively assist female patients in achieving pregnancy. This medication also benefits male patients experiencing fertility challenges, as its treatment often leads to increased testosterone production.

 

HCG is frequently prescribed to female patients as part of a treatment plan aimed at inducing: Ovulation stimulation in cases of subfertility typically caused by poor follicle maturation or anovulation. - Support during the luteal phase. Preparation of follicles for retrieval during controlled ovarian hyperstimulation programs (often utilized in medically assisted reproductive methods).

 

HCG is commonly prescribed to male patients due to its ability to treat hypogonadotropic hypogonadism. Some individuals with idiopathic dysspermias have shown positive responses to this medication. It is also used to address delayed puberty linked to inadequate function of the gonadotropic pituitary glands and for cryptorchidism (excluding cases caused by an abnormal anatomical obstruction).

 

HCG is a widely used treatment that assists both male and female patients in overcoming infertility. Additionally, this medication may have other applications for treating or preventing unspecified medical conditions not detailed here.

 

For female patients seeking HCG treatment: Infertile women undergoing medically assisted reproduction, particularly those requiring in vitro fertilization, often struggle with tubal issues and may face a heightened likelihood of ectopic pregnancies after treatment with this medication. Therefore, early ultrasound checks at the onset of a pregnancy (to confirm if it is intrauterine) are vital. Pregnancies following HCG treatment carry a greater risk of multiples. Women with a history of thrombosis, severe obesity, or thrombophilia should avoid this medication due to their elevated risk for arterial or venous thromboembolic events during or after HCG treatment. Furthermore, female patients who have undergone treatment with this drug may have a higher susceptibility to pregnancy losses.